Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
PIBOSEROD CAS# 152811-62-6
PIBOSEROD
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1638 | 100mg | 605.00 | + Add to cart |
|
| R-C-1638 | 200mg | 905.00 | + Add to cart |
|
| R-C-1638 | 500mg | 1310.00 | + Add to cart |
|
|
|
||||
Product description
Piboserod(SB-207266)is a selective 5-HT4 receptor antagonist which was marketed and manufactured by GlaxoSmithKline(GSK)under the trade name Serlipet for the management of atrial fibrillation and irritable bowel syndrome.In 2007 the Norwegian company Bio-Medisinsk Innovasjon AS(BMI)completed a clinical phase II study to investigate the effect of piboserod in patients with chronic heart failure.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---PIBOSEROD Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
